semaglutide and wound healing Semaglutide, a glucagon-like peptide-1 receptor agonist, inhibits oral squamous cell carcinoma growth through P38 MAPK signaling pathway | Journal of Cancer Research Clinical Oncology Semaglutide | Weight Loss Solution

And that I could bring in that FDAs announcement that happened in November to 2025 that it removed the box warnings about breast cancer risk from hormone replacement therapy products

Emotional and psychological needs of people with diabetes

For patients on semaglutide or tirzepatide, the practical strategy emerging from expert consensus includes resistance training two to three times per week, daily protein targets of 1.21.6 g/kg or higher , and supplementation when food intake falls short

I want and deserve an answer

But neither medullary thyroid cancer (MTC) nor multiple endocrine neoplasia syndrome type 2 (MEN-2) appears anywhere in the funnel neither as a condition checkbox nor as a family-history question